USD 3.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 2.43 Billion | 2.3 Billion | 2.29 Billion | 2.4 Billion | 2.75 Billion | 2.84 Billion |
Cost of Revenue | 771 Million | 720 Million | 714 Million | 760 Million | 777 Million | 844 Million |
Gross Profit | 1.66 Billion | 1.58 Billion | 1.58 Billion | 1.64 Billion | 1.97 Billion | 1.99 Billion |
Operating Expenses | 1.79 Billion | 374 Million | 342 Million | 352 Million | 360 Million | 375 Million |
Selling, General and Administrative Expenses | 153 Million | 138 Million | 90 Million | 128 Million | 128 Million | 144 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 1.64 Billion | -116 Million | -42 Million | -18 Million | -33 Million | -110 Million |
Cost and Expenses | 2.57 Billion | 1.09 Billion | 1.05 Billion | 1.11 Billion | 1.13 Billion | 1.21 Billion |
Operating Income | -132 Million | 592 Million | 1.86 Billion | -336 Million | 1.43 Billion | 2.01 Billion |
Interest Expense | 1.18 Billion | 1.21 Billion | 916 Million | 781 Million | 823 Million | 939 Million |
Income Tax Expense | 120 Million | -318 Million | 690 Million | -147 Million | 467 Million | -64 Million |
Earnings before Tax | -1.2 Billion | -1.55 Billion | 1.72 Billion | -1.03 Billion | 1.28 Billion | -111 Million |
Net Income | -1.2 Billion | -1.34 Billion | 646 Million | -653 Million | 655 Million | -253 Million |
Earnings Per Share Basic | -6.79 | -8.15 | 4.26 | -3.92 | 3.54 | -1.32 |
Earnings Per Share Diluted | -6.79 | -8.15 | 4.25 | -3.91 | 3.49 | -1.31 |
Weighted Average Shares Outstanding | 177.05 Million | 164.36 Million | 152 Million | 166.47 Million | 187.43 Million | 191.82 Million |
Weighted Average Shares Outstanding (Diluted) | 177.05 Million | 164.36 Million | 152.04 Million | 166.98 Million | 185.71 Million | 192.58 Million |
Gross Margin | 0.68 | 0.69 | 0.69 | 0.68 | 0.72 | 0.70 |
EBIT Margin | 0.01 | 0.23 | 0.83 | -0.08 | 0.69 | 0.72 |
Profit Margin | -0.49 | -0.58 | 0.28 | -0.27 | 0.24 | -0.09 |
EBITDA | 18 Million | -318 Million | 2.67 Billion | -200 Million | 2.13 Billion | 960 Million |
Earnings Before Tax Margin | -0.05 | 0.26 | 0.81 | -0.14 | 0.52 | 0.71 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 632 Million | 604 Million | 2.43 Billion | 657 Million | 592 Million | 585 Million |
Cost of Revenue | 194 Million | 194 Million | 771 Million | 235 Million | 175 Million | 167 Million |
Gross Profit | 438 Million | 410 Million | 1.66 Billion | 422 Million | 417 Million | 418 Million |
Operating Expenses | 71 Million | 88 Million | 349 Million | 94 Million | 89 Million | 78 Million |
Selling, General and Administrative Expenses | 71 Million | 88 Million | - | -102 Million | 89 Million | 78 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -3 Million | -517 Million | -681 Million | -5 Million | -1 Million | -158 Million |
Cost and Expenses | 265 Million | 282 Million | 1.12 Billion | 329 Million | 264 Million | 245 Million |
Operating Income | 815 Million | -86 Million | 132 Million | -148 Million | -53 Million | 419 Million |
Interest Expense | 370 Million | 387 Million | 1.18 Billion | 42 Million | 425 Million | 395 Million |
Income Tax Expense | 78 Million | -36 Million | 120 Million | 19 Million | 64 Million | 73 Million |
Earnings before Tax | 496 Million | -434 Million | -1.2 Billion | -535 Million | -402 Million | 171 Million |
Net Income | 329 Million | -77 Million | -1.2 Billion | -345.5 Million | -345.5 Million | -3 Million |
Earnings Per Share Basic | 1.77 | -0.42 | - | -1.93 | -1.93 | -0.02 |
Earnings Per Share Diluted | 1.54 | -0.42 | - | -1.93 | -1.93 | -0.02 |
Weighted Average Shares Outstanding | 185.87 Million | 183.33 Million | 177.05 Million | 179.36 Million | 179.36 Million | 174.75 Million |
Weighted Average Shares Outstanding (Diluted) | 213.63 Million | 183.33 Million | 177.05 Million | 179.35 Million | 179.35 Million | 174.74 Million |
Gross Margin | 0.69 | 0.68 | 0.68 | 0.64 | 0.70 | 0.71 |
EBIT Margin | 1.38 | -0.07 | - | -0.74 | 0.05 | 0.98 |
Profit Margin | 0.52 | -0.13 | -0.49 | -0.53 | -0.58 | -0.01 |
EBITDA | 872 Million | -41 Million | - | -487 Million | 30 Million | 574 Million |
Earnings Before Tax Margin | 1.29 | -0.14 | 0.05 | -0.23 | -0.09 | 0.72 |
9530
1618
ZFCVINDIA
NGLFINE
THEMISMED
8929